Performance evaluation of 70 hepatitis B virus (HBV) surface antigen (HBsAg) assays from around the world by a geographically diverse panel with an array of HBV genotypes and HBsAg subtypes.
OBJECTIVE
This study was conducted by the International Consortium for Blood Safety (ICBS) to identify high-quality test kits for detection of hepatitis B virus (HBV) surface antigen (HBsAg) for the benefit of developing countries.


METHODS
The 70 HBsAg test kits from around the world were evaluated comparatively for their clinical sensitivity, analytical sensitivity, sensitivity to HBV genotypes and HBsAg subtypes, and specificity using 394 (146 clinical, 48 analytical and 200 negative) ICBS Master Panel members of diverse geographical origin comprising the major HBV genotypes A-F and the HBsAg subtypes adw2,4, adr and ayw1-4.


RESULTS
Seventeen HBsAg enzyme immunoassay (EIA) kits had high analytical sensitivity <0.13 IU/ml, showed 100% diagnostic sensitivity, and were even sensitive for the various HBV variants tested. An additional six test kits had high sensitivity (<0.13 IU/ml) but missed HBsAg mutants and/or showed reduced sensitivity to certain HBV genotypes. Twenty HBsAg EIA kits were in the sensitivity range of 0.13-1 IU/ml. The other eight EIAs and the 19 rapid assays had analytical sensitivities of 1 to >4 IU/ml. These assays were falsely negative for 1-4 clinical samples and 17 of these test kits showed genotype dependent sensitivity reduction. Analytical sensitivities for HBsAg of >1 IU/ml significantly reduce the length of the HBsAg positive period which renders them less reliable for detecting HBsAg in asymptomatic HBV infections. Reduced sensitivity for HBsAg with genetic diversity of HBV occurred with genotypes/subtypes D/ayw3, E/ayw4, F/adw4 and by S gene mutants. Specificity of the HBsAg assays was >or=99.5% in 57 test kits and 96.4-99.0% in the remaining test kits.


CONCLUSIONS
Diagnostic efficacy of the evaluated HBsAg test kits differed substantially. Laboratories should therefore be aware of the analytical sensitivity for HBsAg and check for the relevant HBV variants circulating in the relevant population.
Scheiblauer
H
H
Paul-Ehrlich-Institut, Langen, Germany.
El-Nageh
M
M
Diaz
S
S
Nick
S
S
Zeichhardt
H
H
Grunert
H-P
HP
Prince
A
A
D000349:Africa / Q000453:epidemiology; D000595:Amino Acid Sequence; D001208:Asia / Q000453:epidemiology; D003906:Developing Countries; D005188:False Negative Reactions; D005814:Genes, Viral; D005838:Genotype; D014943:Global Health; D006509:Hepatitis B / Q000097:blood / Q000175:diagnosis / Q000453:epidemiology* / Q000821:virology; D006514:Hepatitis B Surface Antigens / Q000097:blood* / Q000145:classification / Q000235:genetics; D006515:Hepatitis B virus / Q000145:classification / Q000235:genetics / Q000276:immunology; D006801:Humans; D007124:Immunoenzyme Techniques / Q000379:methods*; D008969:Molecular Sequence Data; D011933:Reagent Kits, Diagnostic; D012680:Sensitivity and Specificity; D016415:Sequence Alignment; D017386:Sequence Homology, Amino Acid; D013020:South America / Q000453:epidemiology; D014481:United States / Q000453:epidemiology
D006514:Hepatitis B Surface Antigens; D011933:Reagent Kits, Diagnostic
Rev Med Virol. 2004 Jan-Feb;14(1):3-16
14716688
Hepatology. 1997 Dec;26(6):1658-66
9398013
J Virol Methods. 2004 Feb;115(2):217-22
14667538
J Med Virol. 1999 Sep;59(1):19-24
10440803
Dev Biol Stand. 1975;30:78-87
1204978
J Clin Microbiol. 2008 Oct;46(10):3319-24
18701669
Intervirology. 2003;46(6):329-38
14688448
Clin Lab. 2004;50(1-2):49-51
15000220
J Med Virol. 2003 Jan;69(1):33-40
12436475
Jpn J Infect Dis. 2005 Apr;58(2):83-7
15858285
Intervirology. 2007;50(1):45-51
17164557
J Gen Virol. 1988 Oct;69 ( Pt 10):2575-83
3171552
J Med Virol. 2001 Jul;64(3):305-11
11424119
Transfusion. 2007 Jul;47(7):1162-71
17581150
J Viral Hepat. 2004 Mar;11(2):97-107
14996343
J Med Virol. 2006;78 Suppl 1:S66-70
16622881
Lancet. 1990 Aug 11;336(8711):325-9
1697396
J Gen Virol. 2000 May;81(Pt 5):1165-74
10769057
J Clin Microbiol. 2003 Jan;41(1):135-43
12517838
J Gen Virol. 2003 Feb;84(Pt 2):269-275
12560557
Intervirology. 2004;47(6):289-309
15564741
J Gen Virol. 1993 Jul;74 ( Pt 7):1341-8
8336122
Int J Med Sci. 2005;2(1):50-57
15968340
J Virol Methods. 2006 Sep;136(1-2):254-6
16707169
J Gen Virol. 1992 Dec;73 ( Pt 12):3141-5
1469353
J Gen Virol. 2002 Aug;83(Pt 8):2059-2073
12124470
Med Microbiol Immunol. 2007 Dec;196(4):247-52
17503077
J Gen Virol. 2000 Jan;81(Pt 1):67-74
10640543
Asian J Transfus Sci. 2007 Jul;1(2):62-70
21938236
Arch Virol. 1998;143(12):2313-26
9930189
Virology. 1994 Feb;198(2):489-503
8291231
Vaccine. 2002 May 22;20(17-18):2191-6
12009272